Healthcare provider profile · identity verified

Amy A. Cooley, M.D.

Family Practice · ORANGE, VA · NPI 1215950183

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	472	138
Lisinopril	Lisinopril	319	83
Levothyroxine Sodium	Levothyroxine Sodium	282	66
Losartan Potassium	Losartan Potassium	259	75
Metoprolol Succinate	Metoprolol Succinate	258	68
Omeprazole	Omeprazole	245	75
Amlodipine Besylate	Amlodipine Besylate	231	71
Rosuvastatin Calcium	Rosuvastatin Calcium	206	65
Furosemide	Furosemide	177	54
Albuterol Sulfate Hfa	Albuterol Sulfate	142	56
Hydrochlorothiazide	Hydrochlorothiazide	141	46
Metformin Hcl	Metformin Hcl	137	45
Sertraline Hcl	Sertraline Hcl	134	40
Montelukast Sodium	Montelukast Sodium	119	35
Gabapentin	Gabapentin	112	43
Allopurinol	Allopurinol	111	23
Prednisone	Prednisone	104	84
Duloxetine Hcl	Duloxetine Hcl	101	18
Simvastatin	Simvastatin	96	24
Metformin Hcl Er	Metformin Hcl	95	25
Escitalopram Oxalate	Escitalopram Oxalate	92	25
Pantoprazole Sodium	Pantoprazole Sodium	91	25
Synthroid	Levothyroxine Sodium	87	19
Fluoxetine Hcl	Fluoxetine Hcl	82	21
Pravastatin Sodium	Pravastatin Sodium	82	22
Trazodone Hcl	Trazodone Hcl	80	25
Carvedilol	Carvedilol	76	21
Bupropion Xl	Bupropion Hcl	72	16
Buspirone Hcl	Buspirone Hcl	65	17
Eliquis	Apixaban	63	18
Fluticasone Propionate	Fluticasone Propionate	62	19
Lorazepam	Lorazepam	62	17
Azithromycin	Azithromycin	59	51
Venlafaxine Hcl Er	Venlafaxine Hcl	59	suppressed
Tizanidine Hcl	Tizanidine Hcl	51	15
Rybelsus	Semaglutide	50	15
Glimepiride	Glimepiride	49	14
Potassium Chloride	Potassium Chloride	49	17
Atenolol	Atenolol	48	12
Tamsulosin Hcl	Tamsulosin Hcl	48	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	40
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	47	12
Ozempic	Semaglutide	47	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	45	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	18
Lovastatin	Lovastatin	42	suppressed
Famotidine	Famotidine	41	16
Metoprolol Tartrate	Metoprolol Tartrate	41	suppressed
Fluconazole	Fluconazole	40	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	suppressed
Ropinirole Hcl	Ropinirole Hcl	40	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Glipizide Er	Glipizide	38	11
Pregabalin	Pregabalin	38	14
Doxycycline Hyclate	Doxycycline Hyclate	37	34
Symbicort	Budesonide/Formoterol Fumarate	37	15
Alendronate Sodium	Alendronate Sodium	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Meloxicam	Meloxicam	34	13
Breo Ellipta	Fluticasone/Vilanterol	33	11
Cephalexin	Cephalexin	33	29
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Glipizide	Glipizide	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Celecoxib	Celecoxib	31	13
Jardiance	Empagliflozin	31	11
Sumatriptan Succinate	Sumatriptan Succinate	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	suppressed
Estradiol	Estradiol	27	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	24
Baclofen	Baclofen	24	12
Amoxicillin	Amoxicillin	23	20
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Colchicine	Colchicine	22	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Cefuroxime	Cefuroxime Axetil	20	14
Dropsafe Prep Pads	Alcohol Antiseptic Pads	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Clonazepam	Clonazepam	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	15
Alprazolam	Alprazolam	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Clopidogrel	Clopidogrel Bisulfate	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Tramadol Hcl	Tramadol Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	14	13
Ramelteon	Ramelteon	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Topiramate	Topiramate	13	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Nystatin	Nystatin	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error